In support of this notion, MMR inactivation in mouse colorectal cancer (CRC) cells not only resulted in increased TMB, but also dynamic mutational profiles that led to neoantigens renewal in vitro and in vivo; an effect that was not observed in cells proficient for MMR (Germano et al., 2017). The gene discussed is MRC1; the disease is colorectal carcinoma.